Nissim Darvish, M.D., Ph.D.
Senior Managing Director at OrbiMed Advisors
Senior Managing Director at OrbiMed Advisors
Head of Merck Innovation Center
Head of Merck Accelerator
Managing Director at Merck Innovation Hub China and Vice President of Merck Strategy & Transformation China
Director General, National Health Insurance Administration, Ministry of Health and Welfare
Executive Consultant, IBM Global Center of Competence for Healthcare & Life Sciences
Healthcare & Life Science Development Head at Amazon Web Service Great China Region
General Manager at Roche Pharma Taiwan
Head of Citi Commercial Bank, Citibank Taiwan
Co-founder and Chief Technology Officer at Imperative Care
Managing Director at TransLink Capital
Founder and Executive Chairman of Quartet
Deep Learning Solution Architect at NVIDIA
Founder and CEO at Innoplexus AG
Associate at M Ventures
Partner at Orfin Ventures
Senior Investment Director in Buffalo II BioFund at Taiwania Capital
Associate Professor in the Department of Population Medicine at Harvard Medical School
Professor at St. Luke’s International University School of Public Health and Professor Emeritus at Keio University, Tokyo
Founder & Managing Director at Ageing Asia Alliance
Co-founder of Halodoc
Partner at HealthXCapital
Co-founder of PregBuddy & Connected Care
Co-founder of PregBuddy & Connected Care
Co-founder & CEO at Inito
Co-founder and Chief Technology Officer at Helium Health
Founding CEO of Surgical Innovation Associates
Founder of Stats Congo
Founder and CEO at HealthMatch
Innovation Fellow at Massachusetts General Hospital
CEO at Brain Navi Ltd.
Co-founder and Commercial Director at Cobotical
Co-founder and Head of Product at Kiipo
Director of Center for Geriatrics and Gerontology, Taipei Veterans General Hospital
President of Taiwan Association Against Depression
Head of Dr. Tang Psychiatric Clinic and Mind Center
Chief Invention Officer at Imagiroo, LLC
Nissim is a Senior Managing Director at OrbiMed. He is a veteran of the life science industry, with 15 years of experience covering medical technology development, corporate leadership and investment management. Nissim spent eight years with Pitango, where he was a General Partner managing life sciences investments. Nissim was the founder and CEO of Impulse Dynamics, culminating $250 million realization event. Nissim obtained his M.D. and Ph.D. in Biophysics and Physiology from the Technion in Israel, and conducted his postdoctoral research at the NIH. He published over 100 patents, authored 20 publications and received 8 prizes and awards.
Michael has worked on the development of the concept of the Innovation Center for more than three years in his role as Merck Inhouse Consultant before taking over the lead of the Innovation Center in 2015. With an academic background in business administration, information management, and business education he joined the Inhouse Consulting department of Merck in 2010. In this role, Michael worked on different projects dealing with innovation management, strategy and business process management. Prior to that Michael held different international consulting roles at PA Consulting Group, Capco, and PricewaterhouseCoopers. Michael received his diploma from the University of Mannheim in 2005.
Born in Zimbabwe, educated in England and Germany, at home in Darmstadt. Munya Chivasa, 31, has run the whole Merck Accelerator program from the company’s German HQ since June 2015. With a BSc in Biochemistry and Pharmacology as well as a master’s degree in Management, he is ideally qualified for the job. Munya helped conceive the Accelerator and is now responsible for its development, expansion, and smooth running. He also helps startups establish networks of external experts and investors.
Sophie Sun is currently Managing Director of Merck China Innovation Hub and Vice President of Merck Strategy and Transformation China. In this role, she leads the corporate efforts of driving strategic planning and initiatives of innovation and digitalization for Merck in China. Sophie is a member of the global leadership team of Group Strategy & Transformation, and a member of China Country Council for Merck. She is also the Chair of China Digital Council for Merck.
Dr. Po-Chang Lee is Director General of the Administration and also President of Taiwan Organ Registry and Sharing Center. He earned his Medical Doctor degree from Taipei Medical University and also graduated from the Graduate Institute of Technology Law of National Cheng Kung University. Dr. Po-chang Lee has deeply devoted his career to kidney transplantation and organ donation. Meanwhile, He was the Taiwan Medical Model winner of 2013 and also the Medical Contribution Award winner for the Special Contribution of 2017. Since he took office as the Director General of the National Health Insurance Administration in May 2016, various health care reforms have immediately been underway including reinforcing referral systems and building NHI Medicloud system which were highly appreciated by the medical community and the public. Further, Dr. Po-chang Lee won the top 10 managers of 2018 100 MVPs by Manager Today magazine and The Public Service Outstanding Group Contribution Award by the Examination Yuan.
Lenny Chen has spent the past 27 years in diversified areas in the healthcare industry. He brings a combination of artificial intelligence, strategy development, analytics, EMR/EHR, clinical operations, financial management, project management, and Health IT implementation expertise to healthcare institutions. As an Executive Consultant in IBM's Global Center of Competence in Healthcare & Life Sciences, he advises clients in developing their Advanced Analytics/AI strategy. Prior to this, as the Senior Manager of IBM Watson Health’s Clinical Adoption Team, he provided leadership and oversight for Clinical Adoption projects for Watson Health’s Oncology and Genomics solutions in Asia Pacific and China.
Hansen serves as Business Development Lead of Healthcare and Life Science Industry at Amazon Web Service, Greater China. He leads virtual sales and solution architect team to help customers adopt AWS. Hansen was Country Manager of Inception program at NVIDIA. He was also General Manager at Intel Digital Health and Life Sciences business development team of China. He also was key founder and organizer of China Hospital Information Management Alliance Vendor Club, Continua-China committee, China Healthcare Innovation Enterprise Alliance. He helped the government formulate many IT standard of healthcare in China. Hansen has Bachelor’s of Chemistry from Zhejiang University and EMBA from City University of Hong Kong.
Irene is a purpose-driven people leader, with a track record of leading team and business transformation to accelerate business growth. She has 20 years of experience in general management, global strategy development and marketing management in the biopharmaceutical industry, and is currently the General Manager of Roche Pharma Taiwan, a global R&D-based biopharmaceutical company. Irene is a graduate of the University of British Columbia. She received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science, and an MBA from the Wharton School.
Michelle is appointed as Head of Citi Commercial Bank Taiwan. She serves a client base that covers emerging and medium-sized corporates in Taiwan who are growing their business. She helps Taiwanese corporates upgrade, transform, and create ecosystems that closely connect clients, strategic partners and governments to grow together, especially in digital and healthcare sectors. Michelle had roles including Citi Credit Cards, Retail Banking, and Mortgage. She dedicates preparing clients with strategic perspective on the new digitalization era. Michelle also served as sponsor for Citi Women’s Network Taiwan for leadership development, helping talents achieve goals regardless their gender identity.
Yi Yang is a seasoned MedTech executive/entrepreneur. Yi is the co-founder and CTO of Imperative Care, a start-up that is dedicated to finding answers to unsolved problems in stroke. Prior, he was COO of Ostial Corporation, overseeing development, production, and commercialization. Previously, he was co-founder and VP of R&D at CAVU, a medical device startup developing novel technologies for the treatment of obesity. Yi held senior management roles at Boston Scientific Corporation (BSX), EndoTex Interventional Systems, Inc. and EP Technologies, Inc. Yi is the inventor or co-inventor on multiple patents. He holds a B.S. in Mechanical Engineering from UC Berkeley and an M.S. in Mechanical Engineering from Stanford University.
Eric is a Managing Director of TransLink Capital and invests in startups globally at the intersection of health and information technology and next generation retail technologies and services. He supports TransLink’s portfolio companies to engage in Asia and leads the firm’s investment activities in Israel. Eric was the Founding Managing Director of the SOFTBANK Asia Infrastructure Fund (SAIF), a venture capital fund launched by SOFTBANK Corporation in partnership with Cisco Systems in 2000. Eric earned a B.A. in Economics from Harvard College and is a certified acupuncturist.
Arun is the Founder and Executive Chairman of Quartet, a technology company transforming mental health. The Quartet platform enables collaboration between physical and mental health providers, targeted care suggestions, and expansion of mental health resources available to patients. Quartet is based in New York with 200+ staff and has raised over $150 million of capital from leading venture capital firms. Prior to founding Quartet in 2014, Arun serially built technology companies as a General Partner at Accretive. He also held roles at Palantir, McKinsey, and The World Bank. Arun received degrees from the Harvard Kennedy School and Duke University.
Andrew Liu is a senior deep learning solution architect at NVIDIA. He assists customers in building innovative solutions based on NVIDIA technology. His research interests are in the area of applying machine learning algorithms to real-world problems. Prior to NVIDIA, Andrew was a machine learning engineer at Foxconn. He took the lead of the analytical team, developed various kinds of predictive modeling projects centered around manufacturing processes, including defect inspection and predictive maintenance, etc. During the Ph.D. program, he has worked as a visiting scholar at Los Alamos National Laboratory's BioScience Team, working on Human and Environmental Microbiome Projects.
Dr. Gunjan Bhardwaj is the Founder and CEO of the Innoplexus AG. Previously, he was with the Boston Consulting Group and also leader of the global business performance think-tank of Ernst & Young. Gunjan was also partner, senior-editor, and advisor for an online innovation management journal and was a member of the scientific advisory board of a US based non-profit institute researching in complexity sciences in the healthcare industry. Gunjan is a keynote speaker and author of many patent applications and publications in scientific and business journals such as Harvard Business Review. Gunjan teaches at Frankfurt School of Finance and Management.
Tony Chang, Ph.D., MBA, joined Ventures as an analyst in 2016 and transitioned into an Associate with the New Businesses team in April 2017. In this role, Tony has evaluated early stage venture deals spanning across a variety of emerging technology fields, including topics such as vocal biomarker to cultured meat. Prior to M Ventures, Tony was a technology commercialization officer at the University of Western Cape in South Africa where he was responsible for the development of several industry research collaborations and licensing deals. Previously, Tony was a consultant in the strategy practice of EY in Johannesburg.
Adam Finkel focuses on technically differentiated solutions with proven commercial capabilities, from health-tech and cyber to FinTech and mobility. He leads all technology investing within a Detroit-based family office, which has been involved in 100+ investments over the last 40 years. The venture portfolio, largely attracted to deeper-tech and high-IP companies, includes investments spanning the United States and Israel; including Remitly, Qumulo, Sight Machine, Tala, Vicarious, Ambiq Micro, Augury, Kentik and Sight Machine. He also sits on the board of several nonprofit and philanthropic organizations.
Diana possesses expertise in various therapeutic areas of expertise. Serving as Senior Investment Director in Taiwania Capital, a venture capital firm backed by Taiwan Development Council, Diana is responsible for due diligence activities and provides critical support to the portfolio companies. She committed to build the developing biotech ecosystem in Taiwan. Diana envisions herself to lead and be involved in more critical resource allocation decisions in the Global R&D, commercialization, business development, licensing, and alliance management to improve human healthcare. Diana holds an MBA in Finance and Healthcare Management from Columbia Business School in the New York City and a MD from National Taiwan University.
Darren Toh, ScD is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute. He is a pharmacoepidemiologist with an interest in the comparative safety and effectiveness research of medical products. His research has been focused on 1) assessing the risks and benefits of medical products using electronic data collected as part of routine healthcare delivery, and 2) developing and applying privacy-protecting analytic methods to conduct multi-center studies in distributed data networks. Darren received his doctoral degree in Epidemiology from the Harvard School of Public Health.
Naoki Ikegami is Professor at the School of Public Health, St. Luke’s International University, and Professor Emeritus at Keio University, Tokyo. He was Chair of the Department of Health Policy and Management at the Keio School of Medicine, from which he received his MD and PhD. He also received a Master of Arts with Distinction in health services studies from Leeds University (United Kingdom). He has been a visiting professor at the University of Pennsylvania’s Wharton School and Medical School, and President of the Japan Society of Healthcare Administration and the Japan Health Economics Association.
Ms. Janice Chia is Founder & Managing Director at Ageing Asia Alliance, Singapore. Janice started Ageing Asia to drive and nurture opportunities and the development of innovation and solutions that address the evolving needs of the rising aging population. Having accumulated a vast experience from visiting over 350 residential and aged care homes from over 15 countries, Janice has been involved in consulting organizations seeking global best practices in housing, health and care models in the Asian market. Janice also launched several industry initiatives, including, ASPIRE55 Singapore – Asia’s first virtual retirement village, a wellbeing community that offers social, health and care services, but enables members to continue living in their existing homes.
Mr. Tenggono has a storied 31-year career across the Indonesian healthcare landscape. He maintains commissioner positions in one of the top 5 pharmaceutical companies in Indonesia. He has experience in developing the Indonesian, ASEAN and West African markets. As well as serving as Halodoc’s chief advisor, Mr. Tenggono is a co-founder of PT. Tigasatu Medika Pratama, a medical devices distribution and services company in partnership with GE healthcare. Mr. Tenggono holds two Masters' degrees, in Business Strategy and Ministry, as well as a Bachelor's in Accounting.
Seemant leads HealthXCapital, the first early stage healthcare VC in South and Southeast Asia. He was also the CEO - Innovations & Research at Apollo Hospitals. He served as Director on the board of multiple Apollo Hospitals joint venture entities focused on bio-banking, cord blood banking and clinical trials. Seemant has experiences across business consulting at EY, Strategy and transformation at Nokia Solutions Networks and Tata Consultancy Services. Seemant is a graduate of Business Indian School of Business (ISB) with executive education from Berkeley-Haas and Recanati Business School, Tel Aviv. He has a Bachelors in Engineering from the Birla Institute of Technology.
Sivareena is the Co-founder of Connected Care, a healthcare technology company based in Bangalore dedicated to improving the patient relationship, providers’ productivity and medical outcomes. She is a member of the Forbes Healthcare 30 Under 30, a distinguished alumnus of IIT Kharagpur, and the winner of National Entrepreneur Healthcare award from Government of India. She is among the handful of women entrepreneurs selected in Google Launchpad and Google Solve for India programs, awarded by Hon'ble Sudha Murthy and actor Akshay Kumar for her work in healthcare. She is also a mentor for women entrepreneurs at LeanIn, and Facebook SheLeadsTech programs.
Subhadeep is the Co-founder of Connected Care, a healthcare technology company based in Bangalore dedicated to improving the patient relationship, providers’ productivity and medical outcomes. He is a member of the Forbes Healthcare 30 Under 30, Google Launchpad, winner of National Entrepreneur Healthcare award, a distinguished alumnus of IIT Kharagpur, and a short term healthcare research scholar at UC Berkeley. He is among the few Product and SaaS leaders from India who have been invited to several national and international conferences to speak around Product, SaaS, and on Healthcare Technology.
Aayush is the Co-founder & CEO of Inito, a startup building the world's first comprehensive at-home diagnostics device. Inito's 'flat-lens' technology allows diagnostic tests for fertility, diabetes, cholesterol and more on a single device connected to a smartphone. He was named to the Forbes 30 Under 30 Asia - Healthcare in 2019.
Alex is an International IT Professional with over 18 years of disruptive technology experience. He specializes in networked applications, infrastructure and system integration. Alex has worked for notable organizations such as MCI Worldcom, Capital Group Companies and Cisco System’s Netsolve. There, he played key roles in the continued development and support of globally distributed health IT infrastructure for health systems. He is passionate about IT and how it can be used as a tool to improve the access and quality of care.
Alexei Mlodinow, founding CEO at Surgical Innovation Associates (SIA). Alexei is a researcher, inventor, and Forbes 30-Under-30 entrepreneur. He is the founding CEO of Surgical Innovation Associates (SIA), an early-stage medical device company improving outcomes and lowering cost through “for surgeon, by surgeon” innovation in reconstructive and cosmetic surgery. He co-founded SIA during a dual MD-MBA program at Northwestern’s Kellogg School of Management and Feinberg School of Medicine, where he also authored 25+ peer-reviewed publications, presentations, and abstracts in the field of reconstructive plastic surgery. Prior, he graduated at the top of a 5,000+ person class from the University of California with dual degrees in Economics and Japanese.
Nohémie Mawaka is founder of Stats Congo, a Grand Challenges Canada’s Stars in Global Health grant winning idea (2018). She partnered with the Panzi Foundation and a hospital in Bukavu, founded by Nobel Prize winner Dennis Mukwenge, to pilot Stats Congo which aims to create a centralized database of women and children’s health outcomes in the DRC. The idea was scaled using an open source software implemented in computers (MVP), making her a Forbes 30 Under 30 (2018) finalist. Stats Congo is moving forward and strategically implementing this social enterprise within the emerging markets of digital health space.
Manuri Gunawardena is the founder and CEO of HealthMatch, a healthcare technology startup that aims to connect sick patients with clinical trials of potential cutting edge treatments. As a medical student she witnessed patients who had exhausted all traditional medical options, yet struggled to find and access potentially life saving clinical trials. HealthMatch has raised $1.3 million in capital from Australian and U.S. industry leaders and won the inaugural Australian version of TechCrunch Startup Battlefield. Manuri was named as the featured honouree in Forbes 30 Under 30 - Asia - Healthcare & Science 2019.
Rahul used to live as a monk in India, but now is a resident with the Royal Australasian College of Physicians in Internal Medicine/Cardiology. He obtained an MBA at Oxford and an MPH at Harvard. He serves as a National Strategy Advisor for Pallium India, helping scale palliative care operations within the country, and has founded OnTrackBirths: an endeavour bringing maternal care to vulnerable populations on trains. He was a Fulbright Fellow at Harvard's Massachusetts General Hospital before returning to clinical practice in New Zealand, working on optimizing Rheumatic Heart Valve disease management in the South Pacific.
Dr. Chen has backgrounds of medicine and biomedical engineering. He and two STB fellows, Alan and Carson, co-founded the company, iXensor Inc. iXensor focuses on mobile health solution. The PixoTest POCT system and Eveline ovulation system got many awards including Japan Good Design, CES babytech, Taiwan Excellence, and MEDICA mHealth Summit. Dr. Chen also founded another startup company, Brain Navi Ltd., which focuses on innovative navigation system of brain surgery. NaoTrac, the AUTOPILOT brain surgical system, integrates advanced sensing technologies, AI and robots to improve the accuracy and decrease the learning curve for neurosurgeons.
Jack Pearson is the Co-founder of Cobotical, an automation consultancy that develops custom robotic solutions for clients in logistics, agriculture and healthcare. He also advises venture capital firms, supporting them with the identification and selection of deep tech start-ups. Currently Jack is working with Big Idea Ventures on the launch of their first fund. For his efforts promoting innovative technology, the UK’s Royal Academy of Engineering awarded Jack an Enterprise Fellowship and sponsorship for one year. He received his MEng in Engineering Design from the University of Bristol, where he now teaches a short course on commercialising innovation.
Chris is Co-founder and Head of Product at Kiipo, a health-technology social enterprise aiming to make the most advanced health technologies accessible to all. He leads cross-functional design-driven product teams, creating AI-powered products. Chris is widely recognized internationally for having created Ethiopia’s first full-circle Emergency Medical Services (EMS) system—alongside Kiipo Co-founder Jordan Masys—and is a leading voice in integrating design with technology to create real-world impact. Chris is also the founder and President of the nonprofit organization PhysioQ, a platform that promotes medical science breakthroughs with its data collection toolkit. He is also a mentor for Design for Taiwan.
Professor Chen graduated from the Department of Medicine, National Yang-Ming University, and earned his doctor’s degree from the Institute of Health and Welfare Policy, also in National Yang-Ming University. Now, he is the Director of Geriatrics and Gerontology of Taipei Veterans General Hospital and the Director of Aging and Health Research Center of National Yang Ming University at the same time. Prof. Chen is the editor of several international journals focused on geriatrics and and gerontology. He has over 300 publications surrounding the topic.
Chia-Ming Chang is Associate Professor and Director, Division of Rehabilitation & Community Psychiatry, Chang Gung Memorial Hospital at Linkou. Dr. Chang is also currently serves as President of Taiwan Association Against Depression, Member of Council, Taiwan Society of Suicidology, and Secretary General, Taiwanese Society of Psychiatry. Dr. Chang’s research interest is psychiatric epidemiology and has included PTSD, suicide, depression, and big data analysis.
Dr. Tang holds an MD and Master of Psychiatry from Kaohsiung Medical University. He also has a PhD in Psychotherapy, Department of Cardiology, National Taiwan Normal University. He has been a researcher at TISCH Hospital, New York University and at a seminar at the Institute of Psychiatry, King's College London. Dr. Tang is a senior medical psychiatric outpatient director, senior attending physician and senior psychotherapy supervisor. He has more than 20 years of clinical experience. He has served as a consul of the Spiritual Society and the Society of Psychotherapy. Dr. Tang also has served as a government counseling committee member many times.
Lily Born is an internationally recognized student inventor. Her first invention was a no spill cup created for her grandfather when she was 7. She has since produced and sold tens of thousands of the cups throughout the world and been recognized by CNN Heroes as a young wonder, and the US Whitehouse and featured in the Smithsonian Museum of American History as well as Johns Hopkins Center for Talented Youth as well as myriad other publications throughout the world. At 16, she has applied for over ten international patents on the cups and other aids to daily functioning.